Published on 02/12/2025

Verification vs Validation for AI/ML: What Each Proves

Artificial Intelligence and Machine Learning (AI/ML) technologies are increasingly being integrated into various pharmaceutical and clinical solutions. Nevertheless, understanding the difference between verification and validation in the context of AI/ML model validation is crucial for maintaining compliance with regulatory requirements in the US, UK, and EU. This guide aims to provide a comprehensive overview of verification and validation processes, intended use, data readiness, bias testing, and the necessary documentation and audit trails essential for pharmaceutical professionals working in this evolving field.

Understanding Verification and Validation

Verification and validation (V&V) are two distinct but equally important processes in the development and deployment of AI/ML models in the pharmaceutical sector. While both processes contribute to ensuring the reliability and compliance of AI/ML models, they serve different purposes.

What is Verification?

Verification refers to the process of evaluating whether a model or system meets specified requirements at a given stage of its development or life cycle. It involves checking if the model was built correctly according to predefined specifications. In the context of AI/ML, verification ensures that the model functions as designed and that it achieves the intended outcomes with the data it is trained upon.

Key activities in the verification phase may include:

• Confirming that algorithms are implemented correctly.
• Checking data inputs for accuracy and compliance with defined standards.
• Validating the structure and performance of the model against expected outcomes.

What is Validation?

Validation, on the other hand, is the process of evaluating whether a model meets the operational needs and intended use as defined in its requirements. It assesses whether the final product fulfills the user needs and is suitable for its intended purpose. For pharmaceutical AI/ML applications, validation typically focuses on the model’s performance in real-world scenarios.

Validation activities may include:

• Assessing the model’s performance using external datasets.
• Conducting risk assessments to identify potential compliance issues.
• Establishing unbiased fairness and equity in model predictions.

The Role of Intended Use and Data Readiness

An essential component of both verification and validation processes is understanding the model’s intended use and ensuring data readiness. The intended use statement provides clarity on how the model is to be utilized and informs the V&V strategies to be employed during its development.

Intended Use in AI/ML Model Validation

Intended use refers to the specific objectives for which an AI/ML model is designed, developed, and deployed. Clearly articulating the intended use allows pharmaceutical professionals to establish the scope of validation activities. Regulatory bodies such as the FDA emphasize the importance of defining intended use in their guidance documents to ensure compliance.

Importance of Data Readiness

Data readiness involves ensuring that the data utilized for model training, validation, and testing is accurate, complete, and representative of the population it will serve. This emphasizes the need for data curation processes to identify datasets that are reliable, unbiased, and representative.

Key aspects of data readiness include:

• Gathering data that reflect the intended use population.
• Cleaning and processing data to eliminate inaccuracies and biases.
• Implementing robust data management strategies to safeguard data integrity.

Bias and Fairness Testing in AI/ML Models

As AI/ML models are increasingly deployed in critical pharmaceutical infrastructures, ensuring fairness and mitigating bias have become paramount. Bias in AI/ML can lead to inequitable outcomes, especially among underrepresented populations. Bias and fairness testing allows organizations to proactively identify and mitigate these concerns.

Identifying Bias

Bias can emerge from various sources, including:

• Biased training datasets that do not accurately represent the target population.
• Algorithmic bias derived from how the model interprets data.
• Societal biases that can seep into the model through data selection.

Effective methodologies for identifying bias include:

• Analyzing model predictions to determine disparate impacts.
• Utilizing statistical tools to measure bias levels in outcomes.
• Conducting external audits to evaluate breach of fairness standards.

Ensuring Fairness

Once bias has been identified, strategies must be implemented to ensure fairness in AI/ML outcomes. This can consist of:

• Regular re-evaluations of training datasets for representativeness.
• Implementing fairness constraints within the model algorithms.
• Continuously monitoring and adjusting the model post-deployment to tackle newly identified biases.

Documentation and Audit Trails in AI/ML Model Validation

Documentation plays a critical role in maintaining compliance with regulatory standards such as 21 CFR Part 11 and Annex 11. Comprehensive documentation supports all phases of verification and validation and ensures accountability in AI/ML model development.

Types of Documentation

Essential documentation requirements include:

• Requirements Specification: Document defining the model’s intended use and performance expectations.
• Verification and Validation Plans: Comprehensive outlines detailing methodologies and procedures for V&V activities.
• Test Results: Evidence of all conducted verification and validation tests, including outcomes and evaluations.

Maintaining Audit Trails

Audit trails are vital for tracking changes made during the model’s lifecycle. They provide transparency and accountability, essential for compliance with regulatory standards like GAMP 5. Key components of effective audit trails include:

• Documenting all significant changes to model configurations.
• Recording user access to the model and associated data.
• Maintaining logs of any updates to the verification and validation processes.

Drift Monitoring and Re-Validation

Once an AI/ML model is deployed, ongoing monitoring is essential for ensuring its continued compliance and effectiveness. Drift monitoring refers to the systematic observation of model performance over time to detect any changes or degradation in its predictive accuracy and reliability.

The Need for Drift Monitoring

Drift can occur due to several factors, including changes in data distribution, alterations in external conditions, or evolving user needs. Continuous monitoring allows organizations to:

• Detect drift early and take corrective action.
• Ensure the model adapts to new data without compromising performance.
• Maintain the integrity and reliability of the model’s predictions over time.

Re-Validation Activities

When drift is detected, re-validating the model becomes necessary. This may involve:

• Reassessing the target population for data representativeness.
• Re-training the model with updated data to restore predictive capabilities.
• Conducting thorough V&V activities to ensure compliance before redeployment.

AI Governance and Security

Establishing strong governance frameworks is critical in ensuring the ethical use and development of AI/ML models. Governance encompasses the strategies and procedures that guide responsible AI practices through proper oversight, risk management, and compliance with regulatory expectations.

Elements of AI Governance

Effective AI governance incorporates several components:

• Defining roles and responsibilities for stakeholders engaged in AI development and use.
• Establishing protocols for risk assessment and mitigation.
• Creating review processes to evaluate AI outputs for compliance with ethical standards.

Security Measures

Security is a vital aspect of governance, protecting data integrity and confidentiality. Important security practices include:

• Implementing robust data encryption methods and secure access controls.
• Conducting regular security audits and assessments to identify vulnerabilities.
• Staying compliant with relevant regulations such as GDPR and HIPAA where applicable.

Conclusion

As AI/ML technologies continue to shape the pharmaceutical landscape, understanding the nuances of verification and validation is crucial for ensuring compliance with regulatory requirements. By comprehensively addressing intended use, data readiness, bias testing, documentation, drift monitoring, and governance strategies, professionals can navigate the complexities associated with AI/ML model validation. This guide provides a framework to inform processes and support the responsible deployment of AI/ML within the highly regulated environment of pharma and clinical development.